Vera Therapeutics VERA Stock
Vera Therapeutics Price Chart
Vera Therapeutics VERA Financial and Trading Overview
| Vera Therapeutics stock price | 39.69 USD |
| Previous Close | 13.35 USD |
| Open | 12.94 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 800 |
| Day's Range | 12.07 - 13.02 USD |
| 52 Week Range | 5.2 - 23.39 USD |
| Volume | 913.77K USD |
| Avg. Volume | 512.77K USD |
| Market Cap | 563M USD |
| Beta (5Y Monthly) | -0.516197 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.25 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.8 USD |
VERA Valuation Measures
| Enterprise Value | 424.41M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.7462687 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 3.5700254 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Vera Therapeutics Stock Price History
| Beta (5Y Monthly) | -0.516197 |
| 52-Week Change | -8.62% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 23.39 USD |
| 52 Week Low | 5.2 USD |
| 50-Day Moving Average | 7.66 USD |
| 200-Day Moving Average | 12.5 USD |
VERA Share Statistics
| Avg. Volume (3 month) | 512.77K USD |
| Avg. Daily Volume (10-Days) | 1.28M USD |
| Shares Outstanding | 44.26M |
| Float | 20.76M |
| Short Ratio | 9.63 |
| % Held by Insiders | 5.71% |
| % Held by Institutions | 69.67% |
| Shares Short | 2.86M |
| Short % of Float | 8.52% |
| Short % of Shares Outstanding | 6.45% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -35.085% |
| Return on Equity (ttm) | -69.85% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -102040000 USD |
| Diluted EPS (ttm) | -5.1 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 197.15M USD |
| Total Cash Per Share (mrq) | 4.45 USD |
| Total Debt (mrq) | 30.68M USD |
| Total Debt/Equity (mrq) | 19.46 USD |
| Current Ratio (mrq) | 8.689 |
| Book Value Per Share (mrq) | 3.563 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -84907000 USD |
| Levered Free Cash Flow (ttm) | -55361000 USD |
Profile of Vera Therapeutics
| Country | United States |
| State | CA |
| City | Brisbane |
| Address | 8000 Marina Boulevard |
| ZIP | 94005 |
| Phone | 650-770-0077 |
| Website | https://veratx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 46 |
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy; and for treatment of lupus nephritis. It is also developing MAU868, a monoclonal antibody for the treatment of BK viremia infections. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
Q&A For Vera Therapeutics Stock
What is a current VERA stock price?
Vera Therapeutics VERA stock price today per share is 39.69 USD.
How to purchase Vera Therapeutics stock?
You can buy VERA shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Vera Therapeutics?
The stock symbol or ticker of Vera Therapeutics is VERA.
Which industry does the Vera Therapeutics company belong to?
The Vera Therapeutics industry is Biotechnology.
How many shares does Vera Therapeutics have in circulation?
The max supply of Vera Therapeutics shares is 65.8M.
What is Vera Therapeutics Price to Earnings Ratio (PE Ratio)?
Vera Therapeutics PE Ratio is now.
What was Vera Therapeutics earnings per share over the trailing 12 months (TTM)?
Vera Therapeutics EPS is -2.25 USD over the trailing 12 months.
Which sector does the Vera Therapeutics company belong to?
The Vera Therapeutics sector is Healthcare.
Vera Therapeutics VERA included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}